pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

2,267 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT987Endpoints754BioPharma Dive288BioSpace192Fierce Biotech184onclive165globenewswire health73raps
therapy area
allOncology5756Rare Disease1304Cardiology1073Immunology972Hematology971Pulmonology856Vaccines
  • Gan & Lee's Phase 3 obesity successes; J&J touts multiple myeloma data
    Plus news about Sanofi, PharmaMar, Jazz, Rhythm Pharmaceuticals, Spyre and Zymeworks 🇨🇳 Another obesity readout from China: Gan & Lee Pharmaceuticals, a China-based insulin specialist, announced…
    Endpoints · 2mo ago↗ source
  • STAT+: A key European clinical trial registry lacks complete and timely results, an analysis finds
    A new analysis found that results for less than half of the clinical studies registered in a key European database were reported within the required time frame.
    STAT · 2mo ago↗ source
  • Covid vaccination cut risk of adverse heart events, large study finds
    Covid vaccination was also tied to a nearly 24% reduction in all-cause cardiac events in a large study, surprising researchers.
    STAT · 2mo ago
← prev
page 47 of 91
next →
69
fda recalls44
fda medwatch33
fda press25
832
Psychiatry & CNS701
Ophthalmology402
Endocrinology & Metabolism355
Pain353
Infectious Disease343
↗ source
  • Neumora drug fails two more Phase 3 trials, biotech to lay off 35% of staff
    The Really Big Neuroscience Company is proving to be a Really Big Flop with each passing update. Neumora Therapeutics will discontinue its lead depression drug after it failed another two Phase 3 s…
    Endpoints · 2mo ago↗ source
  • Medicare drug price rule may target under-the-skin Keytruda and Opdivo
    For 2029, a federal rule proposes closing a "loophole" that protects medicines transitioning from intravenous administration from price protection.
    BioPharma Dive · 2mo ago↗ source
  • Six leaders working on LGBTQ+ inclusion in biopharma
    It’s been a tough 18 months for the LGBTQ+ community. The American Civil Liberties Union tracked 530 anti-LGBTQ bills across dozens of states this year. Nearly 40% of US workers say ...
    Endpoints · 2mo ago↗ source
  • Lilly scores early positive data for new JAK drug
    Acquired through its purchase of Ajax, the drug showed encouraging effects in patients with hard-to-treat myelofibrosis. To analysts, such results could lead to competition for Incyte’s Jakafi.
    BioPharma Dive · 2mo ago↗ source
  • J&J multiple myeloma drug gains edge in earlier stage disease
    The latest results studying Talvey in combination with Darzalex Faspro support J&J’s efforts to expand the immunotherapy's use.
    BioPharma Dive · 2mo ago↗ source
  • STAT+: Lilly’s Ajax acquisition may have been worth it
    A syphilis drug shortage, Sanofi's diabetes drug approval, and more biotech news from The Readout
    STAT · 2mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and more
    Pfizer hasn't complied with a request to donate emergency penicillin to state health agencies as a backstop to prevent congenital syphilis
    STAT · 2mo ago↗ source
  • STAT+: Where ‘democracy met science,’ 50 years ago
    State Medicaid crackdowns strain home care, WHO leader on Ebola outbreak, and more health news
    STAT · 2mo ago↗ source
  • Lilly puts its stamp at #EHA26 with Jaypirca combo data in CLL, first clinical data from Ajax buyout
    Eli Lilly made a push in blood cancer at this year’s European Hematology Association meeting in Stockholm over the weekend. The drugmaker presented data for Jaypirca combined with the standard of c…
    Endpoints · 2mo ago↗ source
  • Celiac disease is entering a new era of therapeutic innovation
    For the ~1 in 100 people living with celiac, the burden of disease extends far beyond their plate.
    BioPharma Dive · 2mo ago↗ source
  • Planning a successful pivot from lab to clinic
    For sterile injectables, key early decisions can have a significant impact on the products’ development.
    BioPharma Dive · 2mo ago↗ source
  • Opinion: In many South Asian American families, a child’s autism diagnosis is a secret
    “In South Asian households, a child's disability triggers a specific kind of family crisis,” writes child and adolescent psychiatrist Ritu Goel.
    STAT · 2mo ago↗ source
  • Opinion: I’m a pediatrician. I want to prescribe the right AI to my patients
    AI for children requires “randomized controlled trials measuring real developmental outcomes, not engagement metrics,” writes Dua Hassan.
    STAT · 2mo ago↗ source
  • STAT+: One California politician’s unexpected crusade against ultra-processed food
    Jesse Gabriel "has passed more food policy in three years than most legislators enact in their entire careers," says one supporter.
    STAT · 2mo ago↗ source
  • STAT+: Amid confusion over Pfizer’s emergency penicillin program, newborn is diagnosed with preventable syphilis
    Congenital syphilis should be preventable. An Arizona case shows how drug shortages and procedural hurdles are fueling a growing public health crisis.
    STAT · 2mo ago↗ source
  • As states follow Trump’s Medicaid fraud playbook, people with disabilities struggle to find care
    Medicaid cuts and fraud crackdown trickle down to states, threatening people with disabilities.
    STAT · 2mo ago↗ source
  • HMNC Brain Health raises $50M Series B to advance two depression drugs
    HMNC Brain Health has secured $50 million in a Series B fundraise designed to support two psychiatry programs into mid-stage studies. The family-owned German drugmaker Medice led the Series B, whic…
    Endpoints · 2mo ago↗ source
  • STAT+: FDA approves Sanofi diabetes drug for children with stage 3 diabetes
    The FDA has approved a drug that was previously caught in a dispute between career staff and the political appointee head of the CDER.
    STAT · 2mo ago↗ source
  • WHO director-general is profoundly concerned after visit to Ebola outbreak area
    The director-general of the World Health Organization is profoundly worried about the Ebola outbreak in the DRC, he told STAT in an interview.
    STAT · 2mo ago↗ source
  • Biopharma’s 2025 industry pay report; Parabilis sets industry record IPO; and more
    Welcome back to Endpoints Weekly! This week, we opened nominations for our eighth annual Women in Biopharma report. We’re looking to profile 20 scientists, executives, founders and other enterprisi…
    Endpoints · 2mo ago↗ source
  • Opinion: ‘I’m pretty much all in’: An interview with a woman starting medical residency at almost 73
    "There are some physicians that work to 100”: Dawn Zuidgeest-Craft on becoming a medical doctor in her 70s.
    STAT · 2mo ago↗ source
  • STAT+: Trump administration revisits policy to close Medicare drug price negotiation loophole
    Trump administration revisits policy to plug Medicare drug price negotiation loophole.
    STAT · 2mo ago↗ source